882 / 1228
1 Independent assay of RAKR from the manufacturer is required
.
.
2. Calibration methods are established for all brachytherapy sources.
3. Calibration infrastructure (i.e., SSDL availability) is variable.
4. Future improvements forthcoming in calibration methods and infrastructure.